AG

Anchit Gupta

Active Director Director DIN 06436849
DIN 06436849 First appointment Dec 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Dec 2012
Shareholding value •••• Premium profile

About Anchit Gupta

Data last updated:

Anchit Gupta is a Director at Sekhmet Pharmaventures Private Limited (since 2020), Designated Partner at Cohera Partners Llp (since 2026) and Designated Partner at Samara Global Services Llp (since 2023). The companies operate in Pharma, Real Estate and Business Services. The largest current company by reported revenue is Sekhmet Pharmaventures Private Limited at ₹1,064 Cr (FY 2025). Earlier, Anchit Gupta was a Nominee Director at Sms Integrated Facility Services Private Limited (2017–2026) and Director at Cogencis Information Services Limited (2012–2021) and 3 more.

DIN 06436849
Primary Designation Director
Industry Pharma
First Appointment 27 Dec 2012
Oldest Company Age 11 yrs
Largest company Sekhmet Pharmaventures Private Limited · ₹1,064 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Dec 20202020₹1,064 Cr (FY 2025)Active
Designated Partner13 Jun 20262026Active
Designated Partner16 Mar 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director22 Mar 20172000₹524 Cr (FY 2025)Active
Director27 Dec 20122006₹109 Cr (FY 2026)Active
Director14 Oct 20162011₹253 Cr (FY 2023)Active
More Consumer Brands Private Limited U74999MH2018PTC312262
Alternate Director11 Sep 20182018₹4,692 Cr (FY 2025)Active
Oaknet Life Sciences Private Limited U74999MH2015PTC263829
Director11 Nov 20162015₹3.94 Cr (FY 2016)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Oaknet Life Sciences Private Limited
Sekhmet Pharmaventures Private Limited
Samara Global Services Llp
Cohera Partners Llp
Premium access

Shareholding and investment profile for Anchit Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anchit Gupta

Anchit Gupta currently holds 3 directorships: Sekhmet Pharmaventures Private Limited (Director, since 04 Dec 2020, revenue ₹1,064 Cr (FY 2025)); Cohera Partners Llp (Designated Partner, since 13 Jun 2026); Samara Global Services Llp (Designated Partner, since 16 Mar 2023).

Anchit Gupta was first appointed on 27 Dec 2012 as Director at Cogencis Information Services Limited. The most recent appointment on record is 13 Jun 2026 at Cohera Partners Llp.

Anchit Gupta held 5 earlier board appointments: Sms Integrated Facility Services Private Limited (Nominee Director, 22 Mar 2017 to 23 Jan 2026); Cogencis Information Services Limited (Director, 27 Dec 2012 to 21 Jan 2021); Eris Oaknet Healthcare Private Limited (Director, 14 Oct 2016 to 12 May 2022); More Consumer Brands Private Limited (Alternate Director, 11 Sep 2018 to 18 Mar 2019); Oaknet Life Sciences Private Limited (Director, from 11 Nov 2016).

The current boards of Anchit Gupta's companies include Aswin Vikram (Sekhmet Pharmaventures Private Limited), Mukesh Kumar Sitaram Agarwal (Sekhmet Pharmaventures Private Limited), Mukesh Kumar Sitaram Agarwal (Sekhmet Pharmaventures Private Limited), Nikhil Kumar Srivastava (Sekhmet Pharmaventures Private Limited), Santosh Kumar Mahil (Sekhmet Pharmaventures Private Limited), Santosh Kumar Mahil (Sekhmet Pharmaventures Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available